Concepedia

Publication | Closed Access

Treatment of chronic hepatitis delta with pegylated interferon‐α2b

DOI

136

Citations

21

References

2006

Year

Andreas Erhardt, Wolfram H. Gerlich, Christine Starke, Ulrike C. Wend, Andreas Donner, Abdurrahman Sagir, Tobias Heintges, Dieter Häussinger
Liver International

Abstract

The present study indicates that PEG-IFN-alpha2b is a promising treatment option in chronic hepatitis D. Nonresponders could be identified by a less than 3 log decrease of HDV RNA at 6 months of treatment.

References

YearCitations

Page 1